Biotage issues 3 million new shares

On June 27 2005 the board of Biotage AB decided to increase the company’s share capital by means of a new issue of 3 million shares. The shares are subscribed by Svenska Handelsbanken for resale to a limited number of institutional investors in Sweden and abroad. The decision is based on the authorization to the board by the annual general meeting held on April 27 2005. By the new issue, the share capital is increased by SEK 3 million to SEK 67,042,108. The issue price amounts to SEK10.00 per share, corresponding to approx. 97.1 percent of the average volume weighted price paid for the Biotage share on June 27, 2005, and approx. 97.4 percent of the average volume weighted price paid for the share during the ten latest trading days (June 13 – 27 2005). The new shares correspond to approx. 4.5 percent of the capital and votes of Biotage following the issue. After deduction of costs, the new share issue brings the company new capital amounting to approx. SEK 29 million. The motive for the issue and the deviation from the shareholders’ preemption rights is to promptly and efficiently finance a part of the acquisition of Argonaut’s business.